2-Oxoadipic acid, a key metabolite of tryptophan and lysine, reacted with 1,2-diamino-4,5-methylenebenzene in an acidic solution to produce a fluorescent derivative. The reaction product was separated using a Tosoh ODS80Ts column with 20 mmol/L of KH 2 PO 4 -K 2 HPO 4 buffer (pH 7.0) containing 26% methanol at a flow rate 0.8 mL/min. The excitation wavelength of detection was 367 nm, and the emission wavelength was 446 nm. The limit of quantification was 1 pmol per injection, sufficiently sensitive for the determination of 2-oxoadipic acid in human and experimental animal urine.
The nutritional factors affecting the metabolism of tryptophan-niacin have been studied, [1] [2] [3] and we have confirmed that the reaction of ACMS to -aminomuconate-"-semialdehyde, the branch point of tryptophan catabolism that leads to niacin production, is inversely related to the amount of niacin synthesis that occurs in the liver cell. 4, 5) 2-OAA is a common catabolic metabolite of the essential amino acids tryptophan and lysine. We are interested in 2-OAA because excess dietary lysine might lead to a build-up of 2-OAA, which in turn would inhibit the catabolism of ACMS to 2-OAA, thus shunting ACMS (from tryptophan) toward niacin biosynthesis. In addition, we are interested in the relationship between dietary intake of tryptophan and/or lysine and the formation of 2-OAA. We have confirmed that urinary excretion of tryptophan catabolites such as kynurenic acid and xanthurenic acid reflect the intake of tryptophan. 6 ) Hence, we did quantitative analyses of 2-OAA, and learned that 2-oxoadipic aciduria, a rare congenital condition, was present, as first reported in 1975 by Przyrember et al. 7) Since that report, there have been seven reported cases, 8) found mainly by employing organic solvent extraction and GC-MS techniques, 9) but the GC-MS technique is not a practical measurement method for the detection of 2-OAA. Nakamura et al. 10) reported an attractive chemical derivatization method for 2-oxo acids with DMB. Although no examination of the reaction between 2-OAA and DMB was described in their report, we succeeded in producing a fluorescent compound by reacting 2-OAA with DMB, and we developed a separation method based on this fluorescent compound by HPLC.
Here, we describe a new assay for measuring 2-OAA in the urine by HPLC with pre-chemical derivatization.
2-OAA was purchased from Sigma-Aldrich Chemicals (St. Louis, MO). DMB was purchased from Dojinkagaku Labs (Kumamoto, Japan). All the other chemicals and solvents used were of reagent grade.
A DMB solution was made by mixing the following in order: 8.7 mL of H 2 O, 0.049 g of sodium hydrosulfite, 0.7 mL of 2-mercaptoethanol, 0.58 mL of concentrated HCl, and 0.016 g of DMB. The DMB solution was usable for at least 1 month when stored in a refrigerator. 2-Mercaptoethanol and sodium hydrosulfite were added to stabilize DMB during the reaction.
The 2-OAA was derivatized by the method of Nakamura et al. 10) The reaction is shown in Fig. 1 . A total of 0.1 mL of the DMB solution was added to 0.1 mL of the 2-OAA solution or to a urine sample suitably diluted in a microtube with a sealed cap. The reaction was carried out by immersing the microtube in a boiling water bath for 45 min, and the microtube was cooled in ice water for at least 5 min. The resulting reaction mixture was filtered through a 0.45-mm filter (Millipore, Bedford, MA), and the filtrate (5 mL) was injected directly into the HPLC system. The fluorescent compound in the final mixtures was stable for at least 24 h when exposed to room light at room temperature.
Separation of the fluorescent product of 2-OAA in urine was carried out using a Tosoh ODS-80Ts (4:6 i.d. Â 250 mm) column (Tosoh, Tokyo). The mobile phase consisted of a 20-mmol/L KH 2 PO 4 -K 2 HPO 4 buffer (pH 7.0) containing 26% methanol. A flow rate of 0.8 mL/min was used, and the column temperature was maintained at 40 C. Fluorometric detection was done at an excitation wavelength of 367 nm and an emission wavelength of 446 nm.
Stock solutions of 2-OAA were made of concentrations of up to 100 mmol/L with water, and were stored at À20 C. Working standard solutions were diluted from the stock solutions to produce a series of concentrations concentration was then reacted with 0.1 mL of the DMB solution, 5 mL of the reacted mixture containing 0.5, 0.75, 1.25, 2.5, 7.5, and 12.5 pmol of 2-OAA was injected into the HPLC system, and fluorescent intensities corresponding to 2-OAA were measured.
The linearity of the calibration curve was determined by plotting the peak areas (y) of the fluorescent intensity against the standard 2-OAA concentrations (x). The correlation coefficient was greater than 0.99, confirming that the calibration curve was linear over a concentration range of 0.5 to 12.5 pmol per injection for the 2-OAA standard. The typical standard curve can be represented by y (fmol) ¼ 21 þ 118x (r ¼ 0:999). The limit of detection was 0.5 pmol (approximately 80 pg) per injection at a signal-to-noise ratio of 5:1. The limit of quantification was 1 pmol (approximately 160 pg) per injection, sufficiently sensitive for the determination of 2-OAA in human, rat, and mouse urine.
Spot urine samples collected from three healthy young Japanese women was used for validation of the method. The three urine samples were mixed. We removed 9 mL from the mixed urine sample, and then 1 mL of 1 mol/L HCl was added to the urine samples to stabilize 2-OAA. The acidified sample was compared with the optimal basal conditions in the HPLC system, which served as the quality control (QC) sample.
Short-term stability was determined by maintaining the QC urine at room temperature for 24 h, middle-term stability was evaluated by storing the QC urine at 4 C for 7 d, and the long-term stability of 2-OAA was assessed at À20 C for 30 d. The freeze-thaw stability of 2-OAA was determined over three cycles of thawing at 4 C for 12 h and refreezing for 12 h. For each storage condition, five replicates were analyzed in each batch. The 2-OAA concentration after each storage period was related to the initial concentration determined for the samples, which were freshly prepared and processed immediately. The range of change was calculated by the following equation:
Range of change (%)
¼ ðconcentration under each condition =concentration of fresh preparationÞ Â 100:
The stability of 2-OAA over the short-term, the longterm, and the freeze-thaw cycles was found to be þ2, À3, and À2% change respectively as compared to the value for fresh urine, which was taken to be 100%. Under all conditions, 2-OAA in urine was stable.
Within-run precision was calculated by analyzing five replicates of the QC urine on the same day. Between-run precision was determined by triplicate analysis of the QC urine on three separate occasions, and the value on each occasion was calculated by analyzing five replicates. The coefficient of variation (CV) was used to measure the precision:
The CVs of the within-and between-run precision were 0.73% and 0.94% respectively.
Within-run accuracy was measured in different experiments to calculate precision, and was evaluated in the same experiment to ascertain the recovery percentages. Accuracy was expressed as relative error (RE) and determined by the following equation:
The accuracies as shown by RE were 1.4%, À2.1%, and 2.6% at concentrations of 1.25, 3.75, and 6.25 pmol per 5 mL of sample respectively.
These data indicate that the assay was reproducible, accurate, and reliable.
Recovery was calculated using the following formula:
Recovery (%) ¼ðobserved concentration =added concentrationÞ Â 100: Three additional concentrations (1.0 mmol/L, 3.0 mmol/L, and 5.0 mmol/L of 2-OAA, which contained 50, 150, and 250 pmol/0.05 mL of standard 2-OAA), were added to 0.05 mL of the QC urine and then reacted with 0.1 mL of the DMB solution. All analyses were performed in triplicate. Recovery was 101 AE 3, 97 AE 1, and 96 AE 3% respectively.
A typical chromatogram of the reference 2-OAA derivative is shown in Fig. 2A , and the 2-OAA derivative eluted at approximately 14.5 min. When standard 2-OAA was reacted with the DMB-free solution (removing only DMB of the DMB solution), the peak was not detected, as shown in Fig. 2E .
Healthy young Japanese women (21-23 years old, n ¼ 14) were recruited for this experiment. A 24-h urine sample was collected from the second passage of urine on the first day to the first passage on the next day. The urine sample volumes were measured, and 1 mL of 1 mol/L HCl was added to 9-mL urine samples to stabilize 2-OAA. The acidified urine samples were stored at À20 C until needed. This study was reviewed and approved by The Ethical Committee of The University of Shiga Prefecture.
Male rats of the Wistar strain (6 weeks old) and female mice of the ICR strain (6 weeks old) were obtained from CLEA Japan (Tokyo) and immediately placed in individual metabolic cages. The animals were fed ad libitum for 21 d on a niacin-free 20% casein diet.
11) Urine samples (24 h; 10:00 AM-10:00 AM) on the last day were collected in amber bottles containing 1 mL of 1 mol/L HCl, and were stored at À20 C until needed. The care and treatment of the experimental animals conformed to the University of Shiga Prefecture guidelines for the ethical treatment of laboratory animals.
The chromatograms of derivatized urine sample from a human, a rat, and a mouse are shown in Fig. 2B , C, and D respectively. The 2-OAA derivative in the sample was characterized on the basis of its retention time and the entire excitation and emission spectra between 320 and 500 nm. Figure 2F , G, and H are chromatograms of a human urine sample (F), a rat urine sample (G), and a mouse urine sample (H) reacted with DMB-free solution. The total HPLC analysis time was approximately 60 min. There were many reactive compounds in the urine, indicating that the urine samples also contained several measurable 2-oxo acids. In future, we intend to develop simultaneous determination of the other 2-oxo acids in the urine.
The daily urinary excretion levels of 2-OAA in humans, rats, and mice were 14:6 AE 2:8 mmol/d (mean AE SEM, n ¼ 14), 2:9 AE 0:8 mmol/d (mean AE SEM, n ¼ 5), and 0:7 AE 0:1 mmol/d (mean AE SEM, n ¼ 5) respectively. This is the first report on the urinary excretion of 2-OAA in healthy (non 2-OAA aciduria) people, rats, and mice.
The present method can be applied to study tryptophan and lysine metabolism. C. The chromatograms shown in upper level are of standard 2-OAA (A) (2.5 pmol/5 mL), a human urine sample (B) (1.1 pmol/5 mL), a rat urine sample (C) (3.6 pmol/ 5 mL), and a mouse urine sample (D) (6.6 pmol/5 mL) reacted with the DMB solution. The chromatograms in lower level are those of standard 2-OAA (E), a human urine sample (F), a rat urine sample (G), and a mouse urine sample (H) reacted with the DMB-free solution.
